Hämovigilanzbericht 2020 Hämovigilanz-Bericht 2024 2/53 Inhalt Inhalt .................................................................................................................. 2 Abbildungsver

Referenced at:

• Haemovigilance

Further information can be found in the Commission Decision and its annexes, which are available in all EU languages on the European Commission's (EC) website.

• attach_file
  Mustertext Finasterid oder Dutasterid | 494 KB
• link
  Link to the European Commission`s Website

Freedom of information New General information Proactive information from the BASG Procedure for the authorisation of medicinal products Adverse reaction reports of medicinal products for human use Ad

Borderline products Delineation between (veterinary) medicinal products and other products Pursuant to Section 1 (3b) of the Austrian Medicines Act (AMG) or pursuant to Section 2 (5) of the Veterinary

Confirmation for the export of non-medical devices For the export of products that are not marketed as medical devices but may appear to authorities in countries outside the European Union to be medic

FAQ Webshops New Distance selling of human and veterinary medicinal products - FAQs on the requirements for webshops New The requirements are based on the following laws: Federal Act of 2 March 1983 o

Recall due to possible lack of sterility

The French authorities have informed the Federal Office for Safety in Health Care (BASG) that, in addition to the regions already announced, confirmed autochthonous cases of dengue fever have been recorded in the Gironde department in France.

Dem Bundesamt für Sicherheit im Gesundheitswesen (BASG) wurde von der französischen Behörde mitgeteilt, dass in Frankreich, zusätzlich zu den bereits bekannt gegebenen Regionen, bestätigte autochthone Dengue-Fälle im Département Gironde verzeichnet wurden.

Referenced at:

• Update: Dengue - France and overseas territories

The Federal Agency for Safety in Health Care (BASG) has been informed by the Italian authorities that, in addition to the provinces already announced, ID WNV NAT testing for blood and blood component donations has been introduced in Avellino, Italy.